Loading...
XNYS
CNMD
Market cap1.10bUSD
Jul 09, Last price  
36.69USD
1D
9.23%
1Q
-0.14%
Jan 2017
-16.93%
Name

Conmed Corp

Chart & Performance

D1W1MN
XNYS:CNMD chart
P/E
23.48
P/S
0.80
EPS
1.56
Div Yield, %
1.64%
Shrs. gr., 5y
1.12%
Rev. gr., 5y
9.77%
Revenues
1.37b
+5.16%
646,812,000694,288,000742,183,000694,739,000713,723,000725,077,000767,140,000756,755,000734,467,000719,168,000763,520,000796,392,000859,634,000955,097,000862,459,0001,010,635,0001,045,472,0001,244,744,0001,307,015,0001,374,495,000
Net income
47m
-64.47%
-12,507,00041,456,00044,561,00012,137,00030,346,000752,00040,481,00035,939,00032,192,00030,498,00014,664,00055,487,00040,854,00028,620,0009,517,00062,542,000-80,582,00064,459,000132,423,00047,055,000
CFO
171m
+2.23%
64,572,00065,894,00061,149,00025,028,00038,243,000102,993,00095,199,00080,949,00065,176,00048,068,00038,222,00065,566,00074,701,00095,133,00064,531,000111,770,00033,365,000125,348,000166,968,000170,689,000
Dividend
Sep 15, 20250.2 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
IPO date
Jul 23, 1987
Employees
4,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT